LOADING
Comparing NVIDIA Corporation (NVDA) and Eli Lilly and Company (LLY) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | LLY |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $5.05T | -- |
| P/E Ratio | 31.9 | -- |
| Forward P/E | 23.8 | -- |
| PEG Ratio | 0.64 | -- |
| EPS | $6.53 | -- |
| Revenue Growth (YoY) | 85.2% | -- |
| Profit Margin | 63.0% | -- |
| Return on Equity | 114.3% | -- |
| Dividend Yield | 0.02% | -- |
| Beta | 2.20 | -- |
| 52-Week High | $236.26 | -- |
| 52-Week Low | $149.06 | -- |
| Volume | -- | -- |